Cargando…

Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein

Computational methods were used to investigate six anthocyanidins exhibiting antidiabetic activity by inhibiting glucokinase regulatory protein (GKRP) activity. Density functional theory was used to optimise the geometry of anthocyanidins and calculate their quantum chemical properties. A blind dock...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenneth, Christian, Anugrah, Daru Seto Bagus, Julianus, Jeffry, Junedi, Sendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355436/
https://www.ncbi.nlm.nih.gov/pubmed/37467274
http://dx.doi.org/10.1371/journal.pone.0288810
_version_ 1785075141571510272
author Kenneth, Christian
Anugrah, Daru Seto Bagus
Julianus, Jeffry
Junedi, Sendy
author_facet Kenneth, Christian
Anugrah, Daru Seto Bagus
Julianus, Jeffry
Junedi, Sendy
author_sort Kenneth, Christian
collection PubMed
description Computational methods were used to investigate six anthocyanidins exhibiting antidiabetic activity by inhibiting glucokinase regulatory protein (GKRP) activity. Density functional theory was used to optimise the geometry of anthocyanidins and calculate their quantum chemical properties. A blind docking method was employed to conduct a molecular docking study, which revealed that delphinidin (Del), cyanidin (Cya), and pelargonidin (Pel) as potential GKRP inhibitors with the lowest binding free energy of -8.7, -8.6, and -8.6 kcal/mol, corresponding to high binding affinity. The molecular dynamics study further verified the blind docking results by showing high GKRP-F1P complex stability and high binding affinity calculated through the MM/GBSA method, upon the binding of pelargonidin. The lower RMSF values of pivotal GK-interacting residues for GKRP-F1P-Pel compared to GKRP-F1P, as a positive control, indicating pelargonidin ability to maintain the inactive conformation of GKRP through the inhibition of GK binding. The key residues that control the binding of the F1P to GKRP and anthocyanidin to GKRP-F1P were also identified in this study. Altogether, pelargonidin is anthocyanidins-derived natural products that have the most potential to act as inhibitors of GKRP and as antidiabetic nutraceuticals.
format Online
Article
Text
id pubmed-10355436
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-103554362023-07-20 Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein Kenneth, Christian Anugrah, Daru Seto Bagus Julianus, Jeffry Junedi, Sendy PLoS One Research Article Computational methods were used to investigate six anthocyanidins exhibiting antidiabetic activity by inhibiting glucokinase regulatory protein (GKRP) activity. Density functional theory was used to optimise the geometry of anthocyanidins and calculate their quantum chemical properties. A blind docking method was employed to conduct a molecular docking study, which revealed that delphinidin (Del), cyanidin (Cya), and pelargonidin (Pel) as potential GKRP inhibitors with the lowest binding free energy of -8.7, -8.6, and -8.6 kcal/mol, corresponding to high binding affinity. The molecular dynamics study further verified the blind docking results by showing high GKRP-F1P complex stability and high binding affinity calculated through the MM/GBSA method, upon the binding of pelargonidin. The lower RMSF values of pivotal GK-interacting residues for GKRP-F1P-Pel compared to GKRP-F1P, as a positive control, indicating pelargonidin ability to maintain the inactive conformation of GKRP through the inhibition of GK binding. The key residues that control the binding of the F1P to GKRP and anthocyanidin to GKRP-F1P were also identified in this study. Altogether, pelargonidin is anthocyanidins-derived natural products that have the most potential to act as inhibitors of GKRP and as antidiabetic nutraceuticals. Public Library of Science 2023-07-19 /pmc/articles/PMC10355436/ /pubmed/37467274 http://dx.doi.org/10.1371/journal.pone.0288810 Text en © 2023 Kenneth et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kenneth, Christian
Anugrah, Daru Seto Bagus
Julianus, Jeffry
Junedi, Sendy
Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title_full Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title_fullStr Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title_full_unstemmed Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title_short Molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
title_sort molecular insights into the inhibitory potential of anthocyanidins on glucokinase regulatory protein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355436/
https://www.ncbi.nlm.nih.gov/pubmed/37467274
http://dx.doi.org/10.1371/journal.pone.0288810
work_keys_str_mv AT kennethchristian molecularinsightsintotheinhibitorypotentialofanthocyanidinsonglucokinaseregulatoryprotein
AT anugrahdarusetobagus molecularinsightsintotheinhibitorypotentialofanthocyanidinsonglucokinaseregulatoryprotein
AT julianusjeffry molecularinsightsintotheinhibitorypotentialofanthocyanidinsonglucokinaseregulatoryprotein
AT junedisendy molecularinsightsintotheinhibitorypotentialofanthocyanidinsonglucokinaseregulatoryprotein